Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Surgical de-escalation in gynecologic oncology].
Zaccarini F, Sanson C, Maulard A, Scherier S, Pautier P, Leary A, Genestie C, Chargari C, Morice P, Gouy S. Zaccarini F, et al. Among authors: genestie c. Bull Cancer. 2021 Dec;108(12):1155-1161. doi: 10.1016/j.bulcan.2021.06.012. Epub 2021 Oct 7. Bull Cancer. 2021. PMID: 34629168 Review. French.
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ].
Querleu D, Bonnier P, Morice P, Narducci F, Lhomme C, Haie-Meder C, Aubard Y, Baldauf JJ, Barillot I, Castelain B, Cuisenier J, Duvillard P, Genestie C, Houvenaeghel G, Leblanc E, Lefranc JP, Lejeune C, Mathevet P, Pautier P, Romestaing P, Tubiana N, Villet R; Société Française d'Oncologie Gynécologique. Querleu D, et al. Among authors: genestie c. Gynecol Obstet Fertil. 2008 Mar;36(3):338-52. doi: 10.1016/j.gyobfe.2008.01.008. Gynecol Obstet Fertil. 2008. PMID: 18494150 French. No abstract available.
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
Bogorad RL, Courtillot C, Mestayer C, Bernichtein S, Harutyunyan L, Jomain JB, Bachelot A, Kuttenn F, Kelly PA, Goffin V, Touraine P; Benign Breast Diseases Study Group. Bogorad RL, et al. Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14533-8. doi: 10.1073/pnas.0800685105. Epub 2008 Sep 8. Proc Natl Acad Sci U S A. 2008. PMID: 18779591 Free PMC article.
[Breast chondrosarcoma: a case report and review].
Guymar S, Ferlicot S, Genestie C, Gelberg JJ, Blondon J, Le Charpentier Y, Zafrani B. Guymar S, et al. Among authors: genestie c. Ann Pathol. 2001 Apr;21(2):168-71. Ann Pathol. 2001. PMID: 11373590 Review. French.
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial.
Vermij L, Léon-Castillo A, Singh N, Powell ME, Edmondson RJ, Genestie C, Khaw P, Pyman J, McLachlin CM, Ghatage P, de Boer SM, Nijman HW, Smit VTHBM, Crosbie EJ, Leary A, Creutzberg CL, Horeweg N, Bosse T; TransPORTEC consortium. Vermij L, et al. Among authors: genestie c. Mod Pathol. 2022 Oct;35(10):1475-1483. doi: 10.1038/s41379-022-01102-x. Epub 2022 Jun 25. Mod Pathol. 2022. PMID: 35752743 Free PMC article. Clinical Trial.
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Croce S, et al. Among authors: genestie c. Gynecol Oncol. 2022 Nov;167(2):373-389. doi: 10.1016/j.ygyno.2022.07.031. Epub 2022 Sep 14. Gynecol Oncol. 2022. PMID: 36114030 Review.
155 results